跳至主要内容
临床试验/JPRN-UMIN000044311
JPRN-UMIN000044311已完成未知

Effects on the cardiac conduction system revealed by analysis of heart rate variability in the use of Remimazolam (Single-blind, a prospective test) - Effects of Remimazolam on the cardiac conduction system (Single-blind, prospective study)

Kindai University Faculty of Medicine0 个研究点目标入组 70 人开始时间: 2021年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients under the age of 20 at the time of obtaining the consent form 2) Patients with allergies, hypersensitivity or tolerance to the drugs used 3) Patients who meet the contraindications listed in the package insert of the drug to be used 4) Patients with AST (GOT) or ALT (GPT) of 100 IU / L or more in preoperative general clinical examination 5) Patients with Child-Pugh classification B or C 6) Patients with serum creatinine of 2.0 mg / dL or higher in general preoperative laboratory tests 7) Patients who have been using benzodiazepines for a long time 8) Patients with organic abnormalities in the brain who may not be able to properly measure EEG and BIS values 9) Patients scheduled to undergo epidural anesthesia / spinal anesthesia 10) Patients with cardiac pacemakers and ICDs 11) Lactating patients (except with the positive consent of the patient) 12) Other patients judged to be inappropriate by the principal investigator

研究者

相似试验